[Federal Register Volume 62, Number 115 (Monday, June 16, 1997)] [Notices] [Page 32620] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-15761] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Psychopharmacologic Drugs Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA regulatory issues. Date and Time: The meeting will be held on July 14, 1997, 8:30 a.m. to 5 p.m. Location: Holiday Inn, Grand Ballroom, Two Montgomery Village Ave., Gaithersburg, MD. Contact Person: Rhonda W. Stover or Robinette Taylor, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12544. Please call the Information Line for up-to-date information on this meeting. Agenda: The committee will consider proposals to reduce the frequency of required white blood cell count monitoring for Clozaril(clozapine), new drug application (NDA) 19-758, Sandoz Pharmaceutical Corp. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person by July 7, 1997. Oral presentations from the public will be scheduled between approximately 8:30 a.m. and 9:30 a.m. Time allotted for each presentation may be limited. Those desiring to make formal oral presentations should notify the contact person before July 7, 1997, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: June 9, 1997. Michael A. Friedman, Deputy Commissioner for Operations [FR Doc. 97-15761 Filed 6-13-97; 8:45 am] BILLING CODE 4160-01-F